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OBJECTIVE — To examine the association between depressive disorder and insulin resis-
tance in a sample of young adults using the Composite International Diagnostic Interview to
ascertain depression status.
RESEARCH DESIGN AND METHODS — Cross-sectional data were collected from
1,732 participants aged between 26 and 36 years. Insulin resistance was derived from blood
chemistry measures of fasting insulin and glucose using the homeostasis model assessment
method. Those identiﬁed with mild, moderate, or severe depression were classiﬁed as having
depressive disorder.
RESULTS — The 12-month prevalence of depressive disorder was 5.4% among men and
11.7% among women. In unadjusted models mean insulin resistance was 17.2% (95% CI
0.7–36.0%, P  0.04) higher in men and 11.4% (1.5–22.0%, P  0.02) higher in women with
depressive disorder. After adjustment for behavioral and dietary factors, the increased level of
insulin resistance associated with depressive disorder was 13.2% (3.1 to 32.3%, P  0.12) in
men and 6.1% (4.1 to 17.4%, P  0.25) in women. Waist circumference was identiﬁed as a
mediator in the relationship between depression and insulin resistance, reducing the  coefﬁ-
cient in the fully adjusted models in men by 38% and in women by 42%.
CONCLUSIONS — A positive association was found between depressive disorder and in-
sulinresistanceinthispopulation-basedsampleofyoungadultmenandwomen.Theassociation
seemed to be mediated partially by waist circumference.
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T
wo recent meta-analyses reported
that the odds of depression in peo-
ple with type 2 diabetes were twice
that in people without diabetes (1) and
that depressed adults had a 37% in-
creased risk of developing type 2 diabetes
(2). Although this evidence suggests a
causal relationship between depression
and the development of type 2 diabetes,
the underlying pathophysiological mech-
anisms are not clear.
Insulin resistance has been investi-
gated as one of the mechanisms linking
depression to diabetes, and different po-
tential pathways can be identiﬁed. In 40–
60% of people with major depressive
disorder, the hypothalamic-pituitary-
adrenal (HPA) axis is hyperactive. Excess
circulating cortisol and its disruption of
glucoregulatory mechanisms is thought
to lead to hyperinsulinemia and insulin
resistance, eventually leading to diabetes
(3). Alternatively, the relationship be-
tweendepressionandtype2diabetesmay
beexplainedbylifestylefactorsassociated
with depression, including physical inac-
tivityandpoordietaryhabitsthatincrease
the risk of developing insulin resistance.
Common to both of these pathways is
obesity, which is a signiﬁcant risk factor
for increasing insulin resistance and dia-
betes. One hypothesis suggests that hy-
peractivity of the HPA axis associated
with depression promotes intra-
abdominal fat accumulation and there is
some support for this in the literature (4).
A small number of cross-sectional
population-based studies looking at the
association between depression and insu-
lin resistance have reported conﬂicting
results. Some supported a positive associ-
ation between depression and insulin re-
sistance (5–9), others reported no
association (10,11), and one reported an
inverserelationship(12).Withtheexcep-
tion of two studies reporting ﬁndings in
young men aged 19 (9) and 31 (8) years,
allotherstudieshavebeenundertakenon
older populations. Other methodological
limitations of these studies include their
reliance on poorly speciﬁed measures of
depression and their potentially inade-
quate adjustment for confounding
variables.
The key objective of this study was to
examinetherelationshipbetweendepres-
sion and insulin resistance in a large pop-
ulation-based sample of young adults
aged between 26 and 36 years using the
computerized version of the Composite
International Diagnostic Interview
(CIDI). This is the ﬁrst study, as far as we
are aware, to use a fully structured diag-
nostic interview to measure depression
according to DSM-IV criteria and to ex-
amine its association with insulin resis-
tance. We hypothesized that there would
be a positive association between depres-
sion and insulin resistance and that this
association would be explained by the
confounding or mediating effects of clin-
ical and behavioral factors and increasing
abdominal adiposity.
RESEARCH DESIGN AND
METHODS— The data for these
cross-sectional analyses were collected in
the period 2004–2006 from Australian
adults aged 26–36 years as part of the
Childhood Determinants of Adult Health
(CDAH) study, a longitudinal study of
cardiovascular risk factors in the general
Australian population. In 2004 this study
successfully traced 6,840 (80.5%) origi-
nal participants of a 1985 Australia-wide
survey of health and ﬁtness of 8,498
schoolchildren aged between 7 and 15
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two-stage sample. The ﬁrst stage was the
selection of schools. These were chosen
with a probability proportional to the en-
rollment numbers of students aged 10
years in primary schools and 14 years in
secondary schools. In the second stage,
sample groups of boys and girls of each
ageweredrawn,atrandom,fromthetotal
schoolenrollment.Ofthosetraced,5,170
(60.8%) were enrolled and provided data
for the study. Of these, 2,410 attended
oneof34clinicsconductedinmajorcities
and regional centers around Australia.
Participants attended clinics where a
variety of biological, physical, socioeco-
nomic,clinical,andpsychologicalparam-
eters were measured after an overnight
fast.Analyseswererestrictedtoclinicpar-
ticipants who 1) had complete data for
depression, 2) were not pregnant, and 3)
had fasting blood glucose and insulin
measures (n  2,110). A further 142 par-
ticipants were excluded from the analysis
because their fasting insulin and glucose
levelsfelloutsidetherecommendedrange
used to calculate insulin resistance using
the updated homeostasis model assess-
mentmethods(HOMA)(http://www.dtu.
ox.ac.uk). Additional exclusions because
of missing information for one or more
study covariates resulted in a ﬁnal sample
size of 1,732 participants. This study was
approved by the Southern Tasmanian
Health and Medical Human Research
EthicsCommittee.Writteninformedcon-
sent was obtained from all participants.
Assessment of depression
Depression was assessed using the com-
puterized version of the CIDI, a fully
structureddiagnosticinterviewwithgood
reliability and validity (13). The CIDI in-
terview provides current (and lifetime)
psychiatric diagnoses according to
ICD-10 and DSM-IV criteria and was de-
veloped by the World Health Organiza-
tion. In this study we used 12-month
depression determined according to the
criteria of the DSM-IV. The CIDI is espe-
cially suitable for large epidemiological
studies because it can be administered by
lay interviewers, does not require outside
informants or medical records, and does
not assume the presence of a current dis-
order. The computerized versions of
structured interviews offer a number of
advantages over standard paper-and-
pencil administration including im-
proved standardization of diagnosis,
elimination of clinician bias, and high re-
liabilityandconsistencyofadministration
(14). Depression status was analyzed as a
dichotomous variable. Participants classi-
ﬁedasdepressedwerethoseexperiencing
mild, moderate, or severe depressive
disorder.
Insulin resistance
Participants had a fasting blood sample
drawn at the clinic for biochemical test-
ing. Fasting glucose (millimoles per liter)
was measured enzymatically using the
Olympus AU5400 automated analyzer.
Two methods of insulin determination
wereusedduringthefollow-upstudy.In-
sulin (milliunits per liter) was measured
by a microparticle enzyme immunoassay
kit (AxSYM; Abbott, Abbott Park, IL) and
by electrochemiluminescence immuno-
assay (Elecsys Modular Analytics E 170;
Roche Diagnostics, Mannheim, Switzer-
land) with interassay standardization. In-
sulin resistance estimates were derived
from blood chemistry measures of fasting
insulin and glucose according to the up-
dated homeostasis model assessment
(HOMA) methods using the HOMA
calculator (http://www.dtu.ox.ac.uk).
HOMA models are considered appropri-
ate for large-scale epidemiological studies
when more sophisticated measures of in-
sulin resistance are impractical.
Demographic measures
Aself-administeredwrittenquestionnaire
was used to collect sociodemographic in-
formation including age, sex, marital sta-
tus (married or living as married and
single/divorced), highest level of educa-
tion (school only, vocational training, or
tertiary education), and occupation
(managers/professionals, white collar,
blue collar, or not in the workforce).
Dietary habits
Information about dietary habits was as-
sessed using a modiﬁed version of a 127-
itemfoodfrequencyquestionnaire(FFQ).
The version of the FFQ has been used
previously in the Australian 1995 Na-
tional Nutrition Survey and was based on
anexistingFFQdevelopedfortheAustra-
lian population (15). The FFQ assesses
the average number of times the listed
food and beverages were consumed over
the previous 12 months. For each item
participants are asked to choose one of
nine response options ranging from
“never or less than once a week” to “six or
more times per day.” Weekly ﬁsh intake
wasassessedfromthescorespertainingto
the consumption of ﬁsh (fresh, fried,
canned, or frozen). Daily equivalents
werecalculatedforeachoftheFFQitems,
assuming that one serving was consumed
on each occasion. The number of weekly
servings of ﬁsh was calculated by sum-
ming the average consumption per week
for each type of ﬁsh. Alcohol consump-
tion was determined from scores pertain-
ing to the consumption of beer (light,
medium, and full strength), wine (red,
white,andfortiﬁed),winecoolers,spirits,
and liqueurs. Participants were catego-
rized as drinkers or nondrinkers.
Smoking
Cigarette smoking was ascertained by
self-administered questionnaire. Partici-
pants were categorized as having never
smoked, being a former smoker, or being
a current smoker. Current smokers in-
cluded those who were weekly and daily
smokers.
Physical activity
The leisure-time physical activity domain
of the International Physical Activity
Questionnaire (IPAQ) was used as the
measure of physical activity. The IPAQ is
astandardizedself-reportinstrumentthat
measures the frequency, duration, and
level of intensity of leisure, occupational,
commuting, and household/yard activi-
ties for the last 7 days. Total weekly min-
utes spent in moderate and vigorous
intensity leisure-time physical activity
was calculated by multiplying the fre-
quency and duration of activity participa-
tion. The IPAQ has been assessed in two
international studies across 12 countries
and has been found to have very good
levelsofrepeatabilityandfairtomoderate
validitycomparedwithdatafromacceler-
ometers (16).
Waist circumference
Waist circumference was measured in
triplicate at the narrowest point between
the lower costal (10th rib) border and the
iliac crest using a nonstretch tape mea-
sure.Measurementsweretakenattheend
ofanormalexpirationandrecordedtothe
nearest 0.1 cm. The mean of the three
measures is reported.
Medications and polycystic ovary
syndrome
Use of antidepressant medication or oral
contraceptives and the presence of poly-
cystic ovary syndrome (PCOS) were as-
certained as part of a self-administered
questionnaire. Participants were asked to
respond to “Are you currently taking any
medication prescribed by your doctor”
Pearson and Associates
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name of the medication and the reason
theyweretakingit.ThepresenceofPCOS
wasassessedbyaskingwomentorespond
to the following question; “Has your doc-
tor ever told you that you have polycystic
ovaries or PCOS?”
Statistical analysis
Unadjusted characteristics by depressive
status were compared separately in men
and women using the t test, Mann-
Whitney U test, and 
2 test for normal,
non-normal,andcategoricalvariables,re-
spectively. Means  SD, medians and in-
terquartile range (IQR), and percentages
are reported where appropriate. Insulin
resistance was logarithmically trans-
formed for regression modeling.
Theassociationbetweeninsulinresis-
tance (outcome) and depressive status
(exposure) was assessed using linear re-
gressionmodels.Thisanalyticalapproach
waschosenbasedonevidencethatinsulin
resistance is a state-dependent metabolic
abnormalityinindividualswithmajorde-
pressive disorder, suggesting that depres-
sive disorder can cause insulin resistance
(17).
Confounding variables identiﬁed for
inclusion in regression models were
smoking, alcohol consumption, physical
activity, education, ﬁsh consumption,
and, in women, PCOS and use of oral
contraceptives. All unadjusted and ad-
justed models were developed separately
for men and women. Regression models
were constructed to evaluate the effects of
possible confounders using the following
strategies. Baseline models included
terms for age and education; subsequent
models examined the inclusion of group-
ings of additional factors including 1) be-
havioral factors (smoking and physical
activity), 2) dietary factors (alcohol and
ﬁsh consumption), 3) medications in
women, and 4) PCOS. Fully adjusted
models retained only those variables that
were associated with a 15% change in
the  coefﬁcient for depressive status
upon removal of the variable or were sig-
niﬁcant independent predictors (P 
0.05). Mediation analysis was performed
to determine whether antidepressant use
or waist circumference was an
intermediate.
RESULTS— Participants’ demo-
graphic, clinical, and behavioral charac-
teristics are shown in Table 1. Depressive
disorder was present in 5.4% of men and
11.7% of women. A higher proportion of
depressed men and women were former
or current smokers than nondepressed
participants.Depressedwomentendedto
be less physically active than their nonde-
pressed counterparts, to eat less ﬁsh, and
to have a greater waist circumference.
Oralcontraceptiveusewasgreateramong
nondepressed women than among de-
pressed women. A higher proportion of
depressed women also reported having
PCOS.
Whereas the study sample was de-
rived from a nationally representative
sample of children ﬁrst measured in
1985, only one-third participated in the
follow-up in adulthood. Compared with
the general Australian population of sim-
ilarage(25–34years)(Table2),thisstudy
samplehadahigherproportionofprofes-
Table 1—Demographic, behavioral, and clinical characteristics of depressed and nondepressed men and women
Men
P value
Women
P value Depressed Not depressed Depressed Not depressed
n 45 788 105 794
Age (years) 31.4  2.8 31.1  2.5 0.58 30.7  2.5 30.9  2.7 0.56
Married or living as married 26 (58) 544 (69) 0.11 64 (61) 543 (68) 0.13
Professional/managers 19 (42.2) 489 (62.1) 0.04 46 (43.8) 429 (54) 0.25
Education
School only 14 (31) 187 (24) 0.21 35 (33) 206 (26) 0.14
Vocational training 19 (42) 288 (36) 29 (28) 201 (25)
Higher degree 12 (27) 313 (40) 41 (39) 387 (49)
Smoking
Never 19 (42) 474 (60) 0.03 47 (45) 462 (58) 0.03
Former 9 (20) 141 (18) 33 (31) 174 (22)
Current 17 (38) 173 (22) 25 (24) 158 (20)
Leisure time physical activity
No physical activity 12 (27) 209 (27) 0.45 37 (35) 175 (22) 0.01
120 min/week 13 (29) 181 (23) 28 (27) 205 (26)
120–240 min/week 13 (29) 196 (25) 25 (24) 235 (30)
240 min/week 7 (16) 202 (26) 15 (14) 179 (23)
Current alcohol drinking 43 (96) 721 (92) 0.34 80 (76) 662 (83) 0.07
Frequency of weekly ﬁsh consumption 1.5 (0.753.0) 1.5 (1.02.9) 0.61 1.0 (02.0) 1.5 (1.03.0) 0.0001
Waist circumference 92.5  11.5 90.0  10.5 0.12 81.5  14.2 78.0  10.8 0.02
BMI 25 kg/m
2 30 (67) 489 (62) 0.54 49 (47) 295 (37) 0.06
Taking antidepressants 9 (20) 9 (1) 0.0001 33 (31) 20 (2) 0.0001
Oral contraceptives NA NA 14 (13) 177 (22) 0.03
PCOS NA NA 12 (11) 41 (5) 0.01
Fasting insulin (mU/l) 7.2 (5.711.4) 6.4 (4.79.3) 0.07 6.6 (4.710.8) 6.0 (4.78.4) 0.09
Fasting glucose (mmol/l) 5.2 (5.05.6) 5.2 (4.95.4) 0.16 4.9 (4.65.2) 4.8 (4.65.1) 0.33
Insulin resistance 1.04  0.56 0.89  0.57 0.04 0.91  0.42 0.83  0.37 0.02
Data are means  SD, n (%), or median (interquartile range). NA, not applicable.
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lowerproportionofcurrentsmokers,and
the proportion of participants who were
classiﬁed as overweight or obese (BMI
25 kg/m
2) was slightly higher for men
and women (19). The prevalence of de-
pressive disorder in study participants
was similar to that in the general popula-
tion (20) as was the proportion of partic-
ipants taking antidepressants (19).
Table 3 shows the results for the re-
gression analysis of depression on insulin
resistance in men and women. Before ad-
justment, insulin resistance was signiﬁ-
cantlyhigheramongmenwithdepression
(17.2%). This association remained
largely unchanged after adjustment for
demographic,behavioral,anddietaryfac-
tors. It was markedly reduced after ad-
justment for antidepressant use (11.3%).
In the ﬁnal fully adjusted model, the
meaninsulinresistancewas13.2%higher
in men with depressive disorder. Fac-
tors remaining in the fully adjusted
model were age, education, physical ac-
tivity, smoking, alcohol, and antide-
pressant use.
Insulin resistance was signiﬁcantly
higher in women with depression in the
unadjusted model (11.4%). There was
only a slight reduction in the size of asso-
ciation after adjustment for age and edu-
cation (10.0%) and after additional
adjustment for behavioral factors (9.6%).
There were modest reductions in the as-
sociation after adjustment for dietary fac-
tors (8.9%), oral contraceptive and
antidepressant use (8.8%), and PCOS
(8.8%). Factors remaining in the fully
adjusted model were age, education,
PCOS, ﬁsh consumption, and antide-
pressant use.
Inclusion of waist circumference in
fully adjusted regression models reduced
thecoefﬁcientfordepressionby38%in
men and 42% in women. No concurrent
change in the  coefﬁcient for waist cir-
cumferenceinmenorwomenresultedaf-
ter removal of depression from the
regression model, suggesting that waist
circumference is a mediator of the associ-
ation between depression and insulin
resistance.
CONCLUSIONS— In the present
study, we examined the association be-
tween depression status and insulin resis-
tance among healthy younger adults. To
the best of our knowledge this is the ﬁrst
large population-based study including
both young men and women to examine
this association using a structured diag-
nostic interview to assess depression ac-
cording to DSM-IV criteria. In both men
and women we found that depressive dis-
order was signiﬁcantly related to insulin
resistance as indexed by HOMA and that
this relationship remained largely un-
changed after adjustment for demo-
graphic, behavioral, and dietary factors.
This relationship was, however, found to
be partially mediated by waist circumfer-
ence. Similar ﬁndings have been reported
by Everson-Rose et al. (21) in middle-
aged women whereas Pan et al. (6) re-
ported that the odds of insulin resistance
associated with depression increased
from 1.54 in all participants to 1.65 in
overweight and 1.81 in obese men and
women, suggestive of effect modiﬁcation
of depression by weight status on insulin
resistance. With the exception of these
two studies, in the majority of previous
studies, positive associations between de-
pression and insulin resistance have re-
mained signiﬁcant after adjustment for
body composition (BMI, waist circumfer-
ence, or waist-to-hip ratio) (6–9,21).
One of the mechanisms by which de-
pression may contribute to disruptions in
glucose metabolism, central adiposity,
and ultimately type 2 diabetes is thought
to be via activation of the HPA axis. The
HPA axis is sensitive to both physical fac-
tors such as alcohol and smoking, and
psychosocial and socioeconomic factors
such as divorce, unemployment, work-
related stress, poor education, and pov-
erty. These are thought to provide the
basis for conditions such as depression,
which is known to activate the HPA axis.
AlthoughtheHPAaxisfunctionsasapro-
Table 3—Regression of insulin resistance on depression status adjusted for demographic,
clinical, and behavioral characteristics in men and women
Models Ratio of means (95% CI)* P value
Men (n  833)
Unadjusted 1.172 (1.007  1.364) 0.04
Model 1 (age and education) 1.163 (0.999  1.354) 0.05
Model 1 plus behavioral factors† 1.175 (1.012  1.366) 0.03
Model 1 plus dietary factors‡ 1.172 (1.008  1.362) 0.04
Model 1 plus medications§ 1.113 (0.949  1.303) 0.19
Fully adjusted model 1.132 (0.969  1.323) 0.12
Women (n  899)
Unadjusted 1.114 (1.015  1.221) 0.02
Model 1 (age and education) 1.100 (1.004  1.206) 0.04
Model 1 plus behavioral factors† 1.096 (1.000  1.203) 0.05
Model 1 plus dietary factors‡ 1.089 (0.999  1.196) 0.07
Model 1 plus medications§ 1.088 (0.984  1.203) 0.10
Model 1 plus PCOS 1.088 (0.993  1.193) 0.07
Fully adjusted model 1.061 (0.959  1.174) 0.25
Data are ratios of means (95% CI). *Mean insulin resistance of depressed subjects relative to mean insulin
resistance of subjects who were not depressed. †Behavioral factors were physical activity and smoking.
‡Dietary factors were alcohol and ﬁsh consumption. §Medications were antidepressants and oral contra-
ceptive use (women only). Variables remaining in the fully adjusted model for men were age, education,
physical activity, smoking, alcohol, and use of antidepressants and for women were age, education, PCOS,
ﬁsh consumption, and use of antidepressants.
Table 2—Characteristics of study partici-
pants compared with the Australian general
population
Participant
characteristic
CDAH
study
sample
Australian
general
population
Current smokers*
Men 23 34
Women 20 26
Professional/managers
Men 51.7 40
Women 48.3 35
Overweight and obese†
Men 62 58
Women 38 35
Antidepressant use 4 3.6
Depression‡
Men 5.4 5.8
Women 11.7 10.1
Data are %. *Current smokers include those who
smoke daily or weekly. †Overweight and obese
includes individuals with a BMI 25 kg/m
2. ‡De-
pression assessment for the Australian general
population was undertaken using the mood module
of the Primary Care Evaluation of Mental Disorders
(PRIME-MD) instrument. Scoring to determine de-
pression“caseness”usedthePRIME-MDmethodfor
detection of DSM-IV diagnoses.
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intense chronic activation is believed to
lead to permanent derangements of the
HPA axis and increased susceptibility to
disease. Studies on primates have shown
that exposure to moderate psychological
stress is followed by a depressive reaction
and the development of adverse meta-
bolic indicators, including abdominal fat
accumulationandinsulinresistance.Sim-
ilar perturbations in the HPA axis associ-
ated with low socioeconomic status and
leading to visceral obesity have been re-
ported in humans (22).
Because of the cross-sectional nature
of this study, we were not able to deter-
mine whether there is a causal relation-
ship between the development of
depression and insulin resistance via the
mechanisms outlined above. We were
alsolimitedbytheabsenceofameasureof
HPA activity such as cortisol. We could,
however, test the hypothesis that the as-
sociation between depression and insulin
resistanceismediatedthroughabdominal
fat. In men and women, we found the as-
sociationtobepartiallymediatedbywaist
circumference but not eliminated. A
causal association between depression
and insulin resistance that is primarily
mediated by increases in waist circumfer-
enceamongthosewithdepressioncannot
therefore be ruled out.
It is also possible that obesity may be
casual in the etiology of depression. A re-
cent meta-analysis suggested that al-
though most cross-sectional studies
support an association between obesity
and depression in women but not men,
theoveralllevelofevidencewasweakpri-
marily because of a lack of prospective
cohortstudies(23).Theothermechanism
by which depression may contribute to
disruptions in glucose metabolism and
central adiposity is via behavioral factors
such as physical inactivity and poor di-
etary behaviors. In our models we found
that these factors did not substantially ac-
count for the associations.
Contrary to what was expected, anti-
depressants did not seem to be an inter-
mediate but rather a confounder. There
was moderate attenuation of the  coefﬁ-
cient after adjustment for antidepressants
in this study. Whether the antidepres-
sants exert a direct effect on glucose me-
tabolism leading to elevated insulin
resistance or whether the effect is medi-
ated via side effects from the medications
such as increased appetite and weight
gain or sedation remains unclear. A re-
view of the literature (24) suggests that
some antidepressants exert clinically sig-
niﬁcant effects on metabolism that can be
either therapeutic in normalizing glucose
homeostasis or have the opposite effect.
Aprimarypointofdifferencebetween
our study and all prior population-based
studies examining the relationship be-
tween depression and insulin resistance
was the use of the CIDI to determine de-
pression status. Prior studies have used
self-report questionnaires to measure ei-
ther depressive symptoms or depression.
Self-reportmeasuresofdepressiondonot
directly assess clinical diagnostic criteria
but rather the presence or absence of
emotionalsymptomsoveraspeciﬁedtime
period.AsobservedinastudybyFisheret
al. (25), 70% of people with diabetes and
high levels of depressive symptoms as as-
sessed using the CES-D were not clini-
cally depressed. Fisher et al. suggested
that scores on the CES-D may reﬂect a
more general emotional and diabetes-
related distress, rather than a clinical di-
agnosis of depression. Future research in
thisareaneedstodeterminewhethersyn-
dromal depression may be less important
than general distress in the depression-
insulin resistance-diabetes relationship.
Although this study makes important
contributions to the literature, a few lim-
itations should be noted. The temporal
relationship between depression and in-
sulin resistance has not been clearly de-
lineated, because the majority of studies,
including this one, have been cross-
sectional; thus, we are limited in our abil-
ity to infer causality in the etiology of
depression related to insulin resistance. A
secondlimitationisthepossibilityofnon-
response bias, given that analyses were
based on only 25% of the original cohort
sample. Although the prevalence of obe-
sity in our sample was slightly higher for
men and women than in the general pop-
ulation, the 12-month prevalence of de-
pression was similar. Furthermore, the
inclusion of a wide distribution of con-
founders and intermediates suggests that
response bias is unlikely and that the re-
sultsfromthestudyshouldnotbelimited
in terms of their generalizability. Finally,
the inclusion of a young cohort is ac-
knowledged as both a strength and limi-
tation. There is a paucity of studies in
this area on younger populations, so this
studymakesauniquecontributioninthis
way. However, the age range may have
limitedourﬁndings,giventhatinsulinre-
sistance and diabetes risk become more
prevalent with increasing age.
In summary, these results show a sig-
niﬁcant relationship between depressive
disorder and greater insulin resistance in
young adult men and women. This rela-
tionship remained relatively unchanged
after adjustment for behavioral and di-
etary factors but was substantially attenu-
ated and no longer signiﬁcant after
adjustment for waist circumference. The
association with depressive disorder may
be due to confounding by abdominal ad-
iposity; however, a causal association be-
tween depression and insulin resistance
mediated by increases in waist circumfer-
ence among those with depressive disor-
der is also plausible. Further research
shouldbeconductedinanattempttorep-
licate these ﬁndings and clarify the direc-
tional nature of these relationships and
their underlying mechanisms.
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